- Home
- MIST vs ARQQ Comparison
MIST vs ARQQ Comparison
Compare MIST & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ARQQ |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | Canada | United Kingdom |
| Employees | N/A | 91 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 289.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | ARQQ |
|---|---|---|
| Price | $1.16 | $16.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.00 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 1.1M | 571.9K |
| Earning Date | 05-13-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | $381.13 |
| Revenue Next Year | N/A | $212.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $11.52 |
| 52 Week High | $3.06 | $62.00 |
Technical Indicators
Market Signals| Indicator | MIST | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 36.21 | 42.19 |
| Support Level | $1.00 | $15.54 |
| Resistance Level | $1.42 | $17.69 |
| Average True Range (ATR) | 0.06 | 1.86 |
| MACD | -0.00 | -0.52 |
| Stochastic Oscillator | 5.71 | 12.52 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.